Insider Buying: Avalo Therapeutics, Inc. (NASDAQ:AVTX) Major Shareholder Purchases 6,000 Shares of Stock

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. purchased 6,000 shares of Avalo Therapeutics stock in a transaction dated Wednesday, June 14th. The shares were bought at an average price of $3.48 per share, for a total transaction of $20,880.00. Following the acquisition, the insider now owns 1,417,540 shares in […]

Related Keywords

,Avalo Therapeutics Inc ,Nasdaq ,Renaissance Technologies ,Monashee Investment Management ,Goldman Sachs Group Inc ,Avalo Therapeutics Company Profile ,Susquehanna International Group ,Caissa Capital Management Ltd ,Securities Exchange Commission ,Avalo Therapeutics ,Get Rating ,Caissa Capital Management ,Exchange Commission ,Capital Management ,International Group ,Investment Management ,Sachs Group ,Avalo Therapeutics Daily ,